131 related articles for article (PubMed ID: 28818113)
1. Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
Van der Gucht W; Leemans A; De Schryver M; Heykers A; Caljon G; Maes L; Cos P; Delputte PL
Virol J; 2017 Aug; 14(1):157. PubMed ID: 28818113
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus entry inhibitors targeting the F protein.
Sun Z; Pan Y; Jiang S; Lu L
Viruses; 2013 Jan; 5(1):211-25. PubMed ID: 23325327
[TBL] [Abstract][Full Text] [Related]
3. The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
King T; Mejias A; Ramilo O; Peeples ME
PLoS Pathog; 2021 Apr; 17(4):e1009469. PubMed ID: 33831114
[TBL] [Abstract][Full Text] [Related]
4. m
Picavet LW; van Vroonhoven ECN; Scholman RC; Smits YTH; Banerjee R; Besteman SB; Viveen MC; van der Vlist MM; Tanenbaum ME; Lebbink RJ; Vastert SJ; van Loosdregt J
Viruses; 2024 May; 16(5):. PubMed ID: 38793659
[TBL] [Abstract][Full Text] [Related]
5. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
[TBL] [Abstract][Full Text] [Related]
6. Sperm proteases that may be involved in the initiation of sperm motility in the newt, Cynops pyrrhogaster.
Yokoe M; Sano M; Shibata H; Shibata D; Takayama-Watanabe E; Inaba K; Watanabe A
Int J Mol Sci; 2014 Aug; 15(9):15210-24. PubMed ID: 25170808
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication.
Colombo É; Désilets A; Hassanzadeh M; Lemieux G; Marois I; Cliche D; Delbrouck JA; Murza A; Jean F; Marsault E; Richter MV; Leduc R; Boudreault PL
ChemMedChem; 2024 Jan; 19(2):e202300458. PubMed ID: 37864572
[TBL] [Abstract][Full Text] [Related]
8. Emodin inhibits respiratory syncytial virus entry by interactions with fusion protein.
Xiong Y; Tan G; Tao K; Zhou Y; Li J; Ou W; Shen C; Xie T; Zhang C; Hou Y; Ji J
Front Microbiol; 2024; 15():1393511. PubMed ID: 38817970
[TBL] [Abstract][Full Text] [Related]
9. Exploring the secrets of virus entry: the first respiratory syncytial virus carrying beta lactamase.
De Ávila-Arias M; Villarreal-Camacho JL; Cadena-Cruz C; Hurtado-Gómez L; Costello HM; Rodriguez A; Burgos-Florez F; Bettin A; Kararoudi MN; Muñoz A; Peeples ME; San-Juan-Vergara H
Front Microbiol; 2024; 15():1339569. PubMed ID: 38455070
[TBL] [Abstract][Full Text] [Related]
10. The
Ruan P; Dai P; Mao Y; Tang Z; He H; Wu G; Qin L; Tan Y
J Biomol Struct Dyn; 2024 Feb; ():1-12. PubMed ID: 38299600
[TBL] [Abstract][Full Text] [Related]
11. Exploratory Spatial Analysis of in vitro Respiratory Syncytial Virus Co-infections.
Simeonov I; Gong X; Kim O; Poss M; Chiaromonte F; Fricks J
Viruses; 2010 Dec; 2(12):2782-802. PubMed ID: 21994640
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Metabolic Studies of Host Directed Inhibitors for Anti Viral Therapy.
Moore TW; Sana K; Yan D; Krumm SA; Thepchatri P; Snyder JP; Marengo J; Arrendale RF; Prussia AJ; Natchus MG; Liotta DC; Plemper RK; Sun A
ACS Med Chem Lett; 2013 Aug; 4(8):762-767. PubMed ID: 23956816
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus.
Garg R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Hum Vaccin Immunother; 2017 Dec; 13(12):2894-2901. PubMed ID: 28825870
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
[TBL] [Abstract][Full Text] [Related]
15. Syncytia Induction by Clinical Isolates of Human Respiratory Syncytial Virus A.
Gagliardi TB; Criado MF; Proença-Módena JL; Saranzo AM; Iwamoto MA; de Paula FE; Cardoso RS; Delcaro LS; Silva ML; Câmara AA; Arruda E
Intervirology; 2017; 60(1-2):56-60. PubMed ID: 28869960
[TBL] [Abstract][Full Text] [Related]
16. Multi-center evaluation of the cobas
Gibson J; Schechter-Perkins EM; Mitchell P; Mace S; Tian Y; Williams K; Luo R; Yen-Lieberman B
J Clin Virol; 2017 Oct; 95():5-9. PubMed ID: 28818691
[TBL] [Abstract][Full Text] [Related]
17. Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?
Karron RA; Zar HJ
Lancet Respir Med; 2018 Jan; 6(1):65-74. PubMed ID: 28865676
[TBL] [Abstract][Full Text] [Related]
18. Identification of Polo-like kinases as potential novel drug targets for influenza A virus.
Pohl MO; von Recum-Knepper J; Rodriguez-Frandsen A; Lanz C; Yángüez E; Soonthornvacharin S; Wolff T; Chanda SK; Stertz S
Sci Rep; 2017 Aug; 7(1):8629. PubMed ID: 28819179
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus infection influences tight junction integrity.
Kast JI; McFarlane AJ; Głobińska A; Sokolowska M; Wawrzyniak P; Sanak M; Schwarze J; Akdis CA; Wanke K
Clin Exp Immunol; 2017 Dec; 190(3):351-359. PubMed ID: 28856667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
